• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dynamic contrast-enhanced magnetic resonance imaging for risk stratification in patients with prostate cancer.动态对比增强磁共振成像在前列腺癌患者风险分层中的应用
Quant Imaging Med Surg. 2022 Jan;12(1):742-751. doi: 10.21037/qims-21-455.
2
Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.动态对比增强磁共振成像(DCE-MRI)联合扩散加权成像(DWI)定量分析在前列腺癌诊断中的应用评估
Oncol Lett. 2019 Mar;17(3):3077-3084. doi: 10.3892/ol.2019.9988. Epub 2019 Jan 29.
3
The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.扩散加权成像和灌注磁共振成像参数在检测临床显著前列腺癌中的应用。
Can Assoc Radiol J. 2019 Nov;70(4):441-451. doi: 10.1016/j.carj.2019.07.005. Epub 2019 Sep 24.
4
The Assessment of Prostate Cancer Aggressiveness Using a Combination of Quantitative Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.使用定量扩散加权成像和动态对比增强磁共振成像相结合的方法评估前列腺癌的侵袭性
Cancer Manag Res. 2021 Jul 2;13:5287-5295. doi: 10.2147/CMAR.S319306. eCollection 2021.
5
DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.使用快门速度与 Tofts 模型对前列腺进行 DCE-MRI,用于肿瘤特征描述和侵袭性评估。
J Magn Reson Imaging. 2017 Sep;46(3):837-849. doi: 10.1002/jmri.25631. Epub 2017 Jan 16.
6
Comparison of diagnostic performance between diffusion kurtosis imaging parameters and mono-exponential ADC for determination of clinically significant cancer in patients with prostate cancer.扩散峰度成像参数与单指数 ADC 诊断效能比较在前列腺癌患者中判断临床显著癌的价值
Abdom Radiol (NY). 2020 Dec;45(12):4235-4243. doi: 10.1007/s00261-020-02776-0. Epub 2020 Sep 23.
7
Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.术前动态对比增强 MRI 的直方图参数可作为评估前列腺癌 Ki-67 表达的潜在影像学生物标志物。
Cancer Med. 2021 Jul;10(13):4240-4249. doi: 10.1002/cam4.3912. Epub 2021 Jun 12.
8
Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T.3T 下定量扩散加权成像和动态对比增强磁共振成像评估前列腺癌肿瘤侵袭性。
Magn Reson Imaging. 2021 Nov;83:152-159. doi: 10.1016/j.mri.2021.08.009. Epub 2021 Aug 25.
9
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.动态对比增强磁共振成像和扩散加权成像在末端回肠克罗恩病活动分期中的应用
World J Gastroenterol. 2020 Oct 21;26(39):6057-6073. doi: 10.3748/wjg.v26.i39.6057.
10
Multiparametric MRI in detection and staging of prostate cancer.多参数磁共振成像在前列腺癌检测与分期中的应用
Dan Med J. 2017 Feb;64(2).

引用本文的文献

1
Characteristics of quantitative dynamic contrast-enhanced magnetic resonance imaging for orbital space-occupying lesions: A retrospective case series study.眼眶占位性病变的定量动态对比增强磁共振成像特征:一项回顾性病例系列研究。
PLoS One. 2025 Sep 12;20(9):e0332199. doi: 10.1371/journal.pone.0332199. eCollection 2025.
2
Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRI.使用动态对比增强磁共振成像区分前列腺恶性组织与正常组织的示踪剂动力学模型比较
Front Oncol. 2024 Dec 6;14:1450388. doi: 10.3389/fonc.2024.1450388. eCollection 2024.
3
Magnetic Resonance Elastography for the Detection and Classification of Prostate Cancer.磁共振弹性成像用于前列腺癌的检测与分类
Cancers (Basel). 2024 Oct 15;16(20):3494. doi: 10.3390/cancers16203494.
4
Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach.通过超高场多参数磁共振成像方法监测伊马替尼在结直肠癌模型中降低周细胞覆盖率和缺氧诱导因子-1α水平的情况。
J Transl Med. 2024 Jul 31;22(1):712. doi: 10.1186/s12967-024-05497-w.
5
Creating a novel multiparametric magnetic resonance imaging-based biopsy strategy for reducing unnecessary prostate biopsies: a retrospective cohort study.创建一种基于多参数磁共振成像的新型活检策略以减少不必要的前列腺活检:一项回顾性队列研究。
Quant Imaging Med Surg. 2024 Feb 1;14(2):2021-2033. doi: 10.21037/qims-23-875. Epub 2024 Jan 22.
6
Association between Dynamic Contrast-Enhanced MRI Parameters and Prognostic Factors in Patients with Primary Rectal Cancer.原发性直肠癌患者动态对比增强 MRI 参数与预后因素的相关性。
Curr Oncol. 2023 Feb 20;30(2):2543-2554. doi: 10.3390/curroncol30020194.
7
Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging.使用多参数磁共振成像和光谱法预测放射治疗后前列腺癌复发:评估治疗前成像的预后因素
Quant Imaging Med Surg. 2022 Dec;12(12):5309-5325. doi: 10.21037/qims-22-184.
8
Soft tissue sarcoma: correlation of dynamic contrast-enhanced magnetic resonance imaging features with HIF-1α expression and patient outcomes.软组织肉瘤:动态对比增强磁共振成像特征与缺氧诱导因子-1α表达及患者预后的相关性
Quant Imaging Med Surg. 2022 Oct;12(10):4823-4836. doi: 10.21037/qims-22-75.
9
Adversarial training for prostate cancer classification using magnetic resonance imaging.使用磁共振成像进行前列腺癌分类的对抗训练
Quant Imaging Med Surg. 2022 Jun;12(6):3276-3287. doi: 10.21037/qims-21-1089.
10
Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer.多参数磁共振成像对前列腺癌侵袭性进行分级。
Cancers (Basel). 2022 Apr 5;14(7):1828. doi: 10.3390/cancers14071828.

本文引用的文献

1
Comparison of diagnostic performance between diffusion kurtosis imaging parameters and mono-exponential ADC for determination of clinically significant cancer in patients with prostate cancer.扩散峰度成像参数与单指数 ADC 诊断效能比较在前列腺癌患者中判断临床显著癌的价值
Abdom Radiol (NY). 2020 Dec;45(12):4235-4243. doi: 10.1007/s00261-020-02776-0. Epub 2020 Sep 23.
2
Predicting clinically significant prostate cancer from quantitative image features including compressed sensing radial MRI of prostate perfusion using machine learning: comparison with PI-RADS v2 assessment scores.使用机器学习从包括前列腺灌注的压缩感知径向磁共振成像在内的定量图像特征预测具有临床意义的前列腺癌:与PI-RADS v2评估评分的比较
Quant Imaging Med Surg. 2020 Apr;10(4):808-823. doi: 10.21037/qims.2020.03.08.
3
Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.动态对比增强(DCE)磁共振成像:定性和定量参数在评估按Gleason评分和PI-RADS v2分层的前列腺肿瘤中的作用
Abdom Radiol (NY). 2020 Jul;45(7):2225-2234. doi: 10.1007/s00261-019-02234-6.
4
Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study.多参数磁共振成像中定量对比增强灌注动力学在鉴别前列腺癌与慢性前列腺炎中的应用:一项初步研究结果
Br J Radiol. 2019 Aug;92(1100):20190181. doi: 10.1259/bjr.20190181. Epub 2019 Jun 11.
5
Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterization of prostate cancer.动态对比增强磁共振成像中用于前列腺癌检测和特征描述的定量参数。
Oncotarget. 2018 Mar 23;9(22):15997-16007. doi: 10.18632/oncotarget.24652.
6
Does the Prostate Health Index Depend on Tumor Volume?-A Study on 196 Patients after Radical Prostatectomy.前列腺健康指数是否取决于肿瘤体积?——一项对196例前列腺癌根治术后患者的研究。
Int J Mol Sci. 2017 Feb 24;18(3):488. doi: 10.3390/ijms18030488.
7
Complications After Systematic, Random, and Image-guided Prostate Biopsy.系统、随机和图像引导前列腺活检后的并发症。
Eur Urol. 2017 Mar;71(3):353-365. doi: 10.1016/j.eururo.2016.08.004. Epub 2016 Aug 17.
8
Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers.前列腺癌:PI-RADS 版本 2 有助于术前预测临床显著癌症。
Radiology. 2016 Jul;280(1):108-16. doi: 10.1148/radiol.16151133. Epub 2016 Feb 2.
9
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.2014年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议:分级模式的定义及新分级系统的建议
Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530.
10
Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score.前列腺磁共振成像:评估肿瘤体积和表观扩散系数作为预测肿瘤 Gleason 评分的替代生物标志物。
Clin Cancer Res. 2014 Jul 15;20(14):3705-11. doi: 10.1158/1078-0432.CCR-14-0044. Epub 2014 May 21.

动态对比增强磁共振成像在前列腺癌患者风险分层中的应用

Dynamic contrast-enhanced magnetic resonance imaging for risk stratification in patients with prostate cancer.

作者信息

Park Hyungin, Kim Seung Ho, Kim Joo Yeon

机构信息

Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Haeundae-gu, Busan, Korea.

Department of Pathology, Inje University College of Medicine, Haeundae Paik Hospital, Haeundae-gu, Busan, Korea.

出版信息

Quant Imaging Med Surg. 2022 Jan;12(1):742-751. doi: 10.21037/qims-21-455.

DOI:10.21037/qims-21-455
PMID:34993115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8666742/
Abstract

BACKGROUND

To investigate the usefulness of perfusion parameters derived from dynamic contrast-enhanced (DCE)-magnetic resonance imaging (MRI) of patients diagnosed as prostate cancer (PCa) in differentiating clinically significant cancer [CSC, Gleason score (GS) ≥7] from non-CSC (GS 6).

METHODS

A total of 94 patients diagnosed between August 2018 and September 2020 as PCa by radical prostatectomy were included in this retrospective study (mean age: 68.7 years, range, 47-83 years). All of the patients had undergone DCE-MRI on a single 3T-MR scanner. Whole-tumor volume was measured by reviewing a pathologic topographic map as a reference standard. The quantitative DCE perfusion parameters, including volume transfer constant (K), rate constant (k), extracellular extravascular space (EES) volume fraction (v), plasma volume fraction (v) and area of region of interest (ROI) were calculated under an extended Tofts model. A receiver operating characteristic (ROC) curve analysis by pair-wise comparison was performed to compare the diagnostic performances of the perfusion parameters.

RESULTS

The study population comprised GS 6 (n=17), GS 7 (n=57), GS 8 (n=9) and GS 9 (n=11) cases. Among the perfusion parameters, v differed significantly between CSC (0.238±0.095) and non-CSC (0.300±0.126) (P=0.0308). Area under the curve (AUC) was 0.643 (95% CI, 0.538-0.739), and a maximum accuracy of 64%, a sensitivity of 66%, and a specificity of 53% were estimated. Area of ROI also differed significantly between CSC (201.89±163.87 mm) and non-CSC (84.99±85.82 mm) (P=0.0054). AUC was 0.807 (95% CI, 0.713-0.881), and maximum accuracy, sensitivity, and specificity were 81%, 82%, and 76%, respectively.

CONCLUSIONS

Size of the tumor and interstitial space volume fraction are significant parameters in differentiating aggressiveness in PCa.

摘要

背景

探讨动态对比增强(DCE)-磁共振成像(MRI)得出的灌注参数对诊断为前列腺癌(PCa)的患者区分临床显著性癌[CSC, Gleason评分(GS)≥7]与非CSC(GS 6)的作用。

方法

本回顾性研究纳入了2018年8月至2020年9月期间经根治性前列腺切除术诊断为PCa的94例患者(平均年龄:68.7岁,范围47 - 83岁)。所有患者均在一台3T MR扫描仪上接受了DCE-MRI检查。通过回顾病理地形图作为参考标准测量全肿瘤体积。在扩展Tofts模型下计算定量DCE灌注参数,包括容积转移常数(K)、速率常数(k)、细胞外血管外间隙(EES)容积分数(v)、血浆容积分数(vp)和感兴趣区(ROI)面积。通过两两比较进行受试者操作特征(ROC)曲线分析,以比较灌注参数的诊断性能。

结果

研究人群包括GS 6(n = 17)、GS 7(n = 57)、GS 8(n = 9)和GS 9(n = 11)的病例。在灌注参数中,CSC(0.238±0.095)与非CSC(0.300±0.126)之间的v差异有统计学意义(P = 0.0308)。曲线下面积(AUC)为0.643(95%CI,0.538 - 0.739),估计最大准确率为64%,灵敏度为66%,特异度为53%。CSC(201.89±163.87 mm)与非CSC(84.99±85.82 mm)之间的ROI面积也有显著差异(P = 0.0054)。AUC为0.807(95%CI,0.713 - 0.881),最大准确率、灵敏度和特异度分别为81%、82%和76%。

结论

肿瘤大小和间质间隙容积分数是区分PCa侵袭性的重要参数。